Shahrokh (Seve) Falati’s area of legal expertise includes Patent Law; Trademark & Unfair Competition Law; general Intellectual Property Law; and the interdisciplinary legal fields governing legal representation of entrepreneurs and innovators (aka Entrepreneurship Law). Prior to joining the faculty at Albany Law School, for over a decade, Professor Falati worked in private practice, focusing exclusively on representing clients on Intellectual Property Law and related legal matters at two large prominent law firms in New York (Jones Day, and HRFM). He still maintains a small personal private legal practice, aiming to use this as leverage to, at times, connect capable students to companies seeking interns and/or entry level positions. Professor Falati’s practical legal experience includes representing University researchers (including a Nobel Laureate in Medicine), start-up companies developing new technologies, and larger established corporations on their Intellectual Property Law and related legal needs. Professor Falati teaches Patent Law; Trademark & Unfair Competition Law; and Entrepreneurship Law in Emerging Technologies; and he is the Director of Programs for Intellectual Property, Technology Transfer & Entrepreneurship. He is admitted to practice law in New York and Massachusetts, before the United States District Court for the District of Massachusetts, and as a registered patent attorney before the United States Patent & Trademark Office.
Seve emigrated from the Middle East to Europe as a child and began high school there, later attending University in Scotland and England and graduating with a B.Sc. with Honours and a Ph.D., both in Pharmacology. He was fortunate enough to then be offered a Fellowship in Boston and moved from London to Boston and completed a three year Postdoctoral Fellowship at Harvard Medical School / Beth Israel Deaconess Medical Center. Seve's Ph.D. and Postdoctoral Fellowship, both in the field of Blood and Cardiovascular Disease, produced a dozen publications. Four of these publications were high impact first author publications (in
Journal of Experimental Medicine, and two in
Blood) which have since been cited more than 1000 times by subsequent scientific papers. One of these four papers addressed a very difficult long-standing scientific question related to blood and was a major collaboration between more than a dozen Scientists in four prominent institutions in the U.S., U.K, and Canada. Seve started, led and managed the international collaborative project and presented the results on behalf of the multinational team at a large international conference in Sydney, Australia.
Read more: Faculty Spotlight — Professor Falati, Students to Help Entrepreneurs Develop High-Impact Ideas